233 related articles for article (PubMed ID: 20142958)
1. Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.
Angelilli A; Ritch R
Middle East Afr J Ophthalmol; 2009 Jan; 16(1):35-40. PubMed ID: 20142958
[TBL] [Abstract][Full Text] [Related]
2. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
3. Exfoliation syndrome.
Ritch R; Schlötzer-Schrehardt U
Surv Ophthalmol; 2001; 45(4):265-315. PubMed ID: 11166342
[TBL] [Abstract][Full Text] [Related]
4. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M
Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
6. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
7. From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland.
Jonasson F
Acta Ophthalmol; 2009 Aug; 87(5):478-87. PubMed ID: 19664108
[TBL] [Abstract][Full Text] [Related]
8. Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.
Bernstein AM; Ritch R; Wolosin JM
J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S44-S53. PubMed ID: 29547474
[TBL] [Abstract][Full Text] [Related]
9. Why is glaucoma associated with exfoliation syndrome?
Ritch R; Schlötzer-Schrehardt U; Konstas AG
Prog Retin Eye Res; 2003 May; 22(3):253-75. PubMed ID: 12852486
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
Zenkel M
J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
[TBL] [Abstract][Full Text] [Related]
11. Exfoliation syndrome.
Ritch R
Curr Opin Ophthalmol; 2001 Apr; 12(2):124-30. PubMed ID: 11224719
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
Aragon-Martin JA; Ritch R; Liebmann J; O'Brien C; Blaaow K; Mercieca F; Spiteri A; Cobb CJ; Damji KF; Tarkkanen A; Rezaie T; Child AH; Sarfarazi M
Mol Vis; 2008 Mar; 14():533-41. PubMed ID: 18385788
[TBL] [Abstract][Full Text] [Related]
13. Review: The role of LOXL1 in exfoliation syndrome/glaucoma.
Whigham BT; Allingham RR
Saudi J Ophthalmol; 2011 Oct; 25(4):347-52. PubMed ID: 23960948
[TBL] [Abstract][Full Text] [Related]
14. Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population.
Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
Mol Vis; 2013; 19():1006-16. PubMed ID: 23687437
[TBL] [Abstract][Full Text] [Related]
15. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma.
Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S
Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Glaucoma in Exfoliation Syndrome.
Ozaki M
J Glaucoma; 2018 Jul; 27 Suppl 1():S83-S86. PubMed ID: 29432334
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
[TBL] [Abstract][Full Text] [Related]
18. Ocular and systemic manifestations of exfoliation syndrome.
Ritch R
J Glaucoma; 2014; 23(8 Suppl 1):S1-8. PubMed ID: 25275896
[TBL] [Abstract][Full Text] [Related]
19. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
20. The T allele of lysyl oxidase-like 1 rs41435250 is a novel risk factor for pseudoexfoliation syndrome and pseudoexfoliation glaucoma independently and through intragenic epistatic interaction.
Guadarrama-Vallejo D; Miranda-Duarte A; Zenteno JC
Mol Vis; 2013; 19():1937-44. PubMed ID: 24068861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
